TLANIST Awards $153 M to NIIMBL
The National Institute of Standards and Technology (NIST) https://www.nist.gov, has awarded $153 million to the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) https://niimbl.force.com.NIIMBL is a public-private partnership ready to accelerate innovation in the biopharmaceutical industry. The U.S. biopharmaceutical industry produces vaccines, monoclonal antibodies, gene therapies, and other medical products derived from biological sources. The []
🗓 Posted August 9, 2021 by Carolyn Bloch
Read the full article at http://federaltelemedicine.com/?p=9618